[
    [
        {
            "time": "2021-07-15",
            "original_text": "Johnson & Johnson (JNJ) Stock Moves -0.09%: What You Should Know",
            "features": {
                "keywords": [
                    "Johnson & Johnson",
                    "Stock Moves",
                    "-0.09%"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 4,
                "Impact": 2,
                "Duration": 1,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-07-15",
            "original_text": "Emergent's (EBS) 5-Year Deal to Back J&J's Coronavirus Vaccine",
            "features": {
                "keywords": [
                    "Emergent",
                    "5-Year Deal",
                    "J&J",
                    "Coronavirus Vaccine"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-07-15",
            "original_text": "U.S. government awards Novavax $1.6 billion for coronavirus vaccine",
            "features": {
                "keywords": [
                    "U.S. government",
                    "Novavax",
                    "$1.6 billion",
                    "coronavirus vaccine"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        }
    ]
]